Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
about
Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@ast
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@en
type
label
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@ast
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@en
prefLabel
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@ast
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@en
P2093
P1476
Phase II trial of cyclophospha ...... outhwest Oncology Group study.
@en
P2093
Al-Sarraf M
Costanzi JJ
Crawford ED
O'Bryan RM
Smith JA Jr
Stephens RL
P304
P577
1985-02-01T00:00:00Z